Literature DB >> 18190960

Clinical and molecular aspects of Turkish familial hemophagocytic lymphohistiocytosis patients with perforin mutations.

Hamza Okur1, Gunay Balta, Nurten Akarsu, Ahmet Oner, Turkan Patiroglu, Ali Bay, Tulin Sayli, Sule Unal, Aytemiz Gurgey.   

Abstract

The aim of this study was to elucidate the pathologic sequence changes and associated clinical phenotypes in 9 new patients showing homozygosity for perforin gene among a total of 37 (24%) Turkish FHL families studied by linkage analysis. These 9 unrelated patients (5M/4F) were coming from consanguineous families and their presentation ages of systemic symptoms were ranged from birth to 15 years. Direct sequencing of coding exons of the perforin gene led to the identification of five different homozygous alterations. The nonsense W374X mutation was identified in three patients while four different missense mutations namely G149S, V50M, A91V and novel A523D were detected in the rest six patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190960     DOI: 10.1016/j.leukres.2007.11.033

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

Review 1.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

2.  Structural and functional analysis of perforin mutations in association with clinical data of familial hemophagocytic lymphohistiocytosis type 2 (FHL2) patients.

Authors:  Omer An; Attila Gursoy; Aytemiz Gurgey; Ozlem Keskin
Journal:  Protein Sci       Date:  2013-06       Impact factor: 6.725

3.  Reactive hemophagocytic lymphohistiocytosis after hepatitis a infection.

Authors:  Perihan Yasemen Canoz; Elif Afat; Fatih Temiz; Nuri Onur Azizoglu; Hatice Bulbul Citilcioglu; Gokhan Tumgor; Goksel Leblebisatan; Mehmet Turgut
Journal:  Indian J Hematol Blood Transfus       Date:  2013-03-07       Impact factor: 0.900

4.  The clinical and laboratory evaluation of familial hemophagocytic lymphohistiocytosis and the importance of hepatic and spinal cord involvement: a single center experience.

Authors:  Burcin Beken; Selin Aytac; Gunay Balta; Baris Kuskonmaz; Duygu Uckan; Sule Unal; Mualla Cetin; Fatma Gumruk
Journal:  Haematologica       Date:  2017-11-16       Impact factor: 9.941

5.  Spinal cord involvement in a child with familial hemophagocytic lymphohistiocytosis.

Authors:  Muge Gokce; Gunay Balta; Sule Unal; Kader Oguz; Mualla Cetin; Fatma Gumruk
Journal:  J Pediatr Neurosci       Date:  2012-09

6.  Familial Hemophagocytic Lymphohistiocytosis with A665G Perforin Gene Mutation: A Case Report.

Authors:  Idil Yenicesu; De Saint Basile Geneviève; Hamdi Cihan Emeksiz; Buket Dalgıç
Journal:  Turk J Haematol       Date:  2012-10-05       Impact factor: 1.831

Review 7.  Hemophagocytic lymphohistiocytosis: review of etiologies and management.

Authors:  Melissa R George
Journal:  J Blood Med       Date:  2014-06-12

8.  Late-onset hemophagocytic lymphohistiocytosis with neurological presentation.

Authors:  Sarah Benezech; Thierry Walzer; Emily Charrier; Damien Heidelberg; Geneviève De Saint-Basile; Yves Bertrand; Alexandre Belot
Journal:  Clin Case Rep       Date:  2017-09-12

9.  Type 2 familial hemophagocytic lymphohistiocytosis in half brothers: A case report.

Authors:  Chunxia Liu; Ming Li; Xiaomei Wu; Xiaojian Yao; Li Zhao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

10.  Unusual Prominent Pulmonary Involvement in a Homozygous PRF1 Gene Variant in a Female Patient.

Authors:  Fahad Alsohime; Talal Almaghamsi; Talal A Basha; Hosam Alardati; Malak Alghamdi; Yousef Mohammed Hawsawi
Journal:  J Clin Immunol       Date:  2020-09-28       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.